Changzhou City, China, Dec. 11, 2023 (GLOBE NEWSWIRE) -- JIN MEDICAL INTERNATIONAL LTD. (the 'Company' or “JinMed”) (NASDAQ: ZJYL), a Cayman Islands holding company with Chinese operating entities that manufacture and develop wheelchairs and living aids products, today announced that it has secured orders of RMB 66 million (approximately $9.18 million USD) of their innovative Micro-Hyperbaric Oxygen Chamber equipment (S-type and M-type) from Conlo Industrial Development (Shanghai) CO., LTD.

中国常州市，2023年12月11日（环球通讯社）--JIN MEDICAL INTERNATIONAL LTD.（以下简称“公司”或“JinMed”）（纳斯达克：ZJYL），一家开曼群岛控股公司，与中国经营实体共同生产和开发轮椅和生活辅助产品，今天宣布，该公司已从康洛工业发展（上海）有限公司获得6600万元人民币（约合918万美元）的创新型微型高压氧舱设备（S型和M型）订单。

(“Conlo”). Building on the successful launches of its MINI micro-hyperbaric oxygen chamber and hydrogen generation machine products in this September, JinMed has recently unveiled S-type (accommodating 2-3 people) and M-type (accommodating 4-6 people) micro-hyperbaric oxygen chambers. Engineered with precision and designed for optimal therapeutic benefits, these chambers are intended to redefine standards in the healthcare industry.

（“Conlo”）。在今年9月成功推出微型高压氧舱和制氢机产品的基础上，JinMed最近推出了S型（可容纳2-3人）和M型（可容纳4-6人）微型高压氧舱。这些腔室经过精密设计，旨在获得最佳治疗效果，旨在重新定义医疗保健行业的标准。

Conlo, recognizing the potential of these innovative products, has placed substantial orders totaling RMB 66 million, encompassing 200 units of each chamber type. Anticipating robust demand, Conlo plans to deploy 10,000 oxygen chambers for human and 10,000 pet oxygen chambers, all of which will be exclusively sourced from JinMed in the Chinese market over the next three years.

康洛认识到这些创新产品的潜力，已下了总计6600万元人民币的大量订单，每种腔室类型共有200台。预计需求旺盛，Conlo计划部署10000个人体氧气室和10000个宠物氧气室，在未来三年内，所有这些氧气室都将在中国市场独家从JinMed采购。

This strategic collaboration underlines JinMed's commitment to delivering innovative healthcare solutions and meeting the evolving needs of its consumers. Mr. Erqi Wang, the Chairman and CEO of the Company commented: 'The Micro-Hyperbaric Oxygen Chamber equipment, developed by JinMed, represents a breakthrough in the field of medical technologies.

这一战略合作突显了JinMed致力于提供创新的医疗保健解决方案并满足其消费者不断变化的需求。该公司董事长兼首席执行官王尔奇先生评论道：“由JinMed开发的微型高压氧舱设备代表了医疗技术领域的突破。

Securing RMB 66 million in orders for our Micro-Hyperbaric Oxygen Chamber equipment demonstrates the trust our business partners have p.

获得6600万元人民币的微型高压氧舱设备订单，证明了我们的商业伙伴对p的信任。